Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Galy

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Blood|December 17, 2005
The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cellsAurélie Olivier, Evelyne Lauret, Patrick Gonin, et al.
Expert Opinion on Biological Therapy|January 16, 2008
Development of lentiviral gene therapy for Wiskott Aldrich syndromeAnne Galy, Maria-Grazia Roncarolo, Adrian J Thrasher
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cellsDiego Laderach, Daniel Compagno, Olivier Danos, et al.
Frontiers in Immunology|April 18, 2018
Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4<sup>+</sup> and CD8<sup>+</sup> T-Cell ResponsesJulie Vendomèle, Safa Dehmani, Quentin Khebizi, et al.
Scientific Reports|November 4, 2025
Combined effects of restriction factors and transduction adjuvants on lentiviral vector gene transfer efficacyMarie Dewannieux, Fatoumata Fofana, Kathleen Hamon, et al.
Developmental Biology|August 9, 2002
Activated MAPK/ERK kinase (MEK-1) induces transdifferentiation of pigmented epithelium into neural retinaAnne Galy, Bertrand Néron, Nathalie Planque, et al.
Medecine Sciences : M/S|December 18, 2015
[Efficacy and safety of gene therapy for Wiskott-Aldrich syndrome]Anne Galy, Guillaume Corre, Marina Cavazzana, et al.
International Immunology|October 3, 2002
4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cellsDiego Laderach, Mojgan Movassagh, Anthony Johnson, et al.
Human Gene Therapy Methods|October 25, 2013
Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancersDina Ingrao, Saliha Majdoul, Ababacar K Seye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2015
Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 VectorsMaxime Ferrand, Sylvie Da Rocha, Guillaume Corre, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Blood|December 17, 2005
The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cellsAurélie Olivier, Evelyne Lauret, Patrick Gonin, et al.
Expert Opinion on Biological Therapy|January 16, 2008
Development of lentiviral gene therapy for Wiskott Aldrich syndromeAnne Galy, Maria-Grazia Roncarolo, Adrian J Thrasher
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cellsDiego Laderach, Daniel Compagno, Olivier Danos, et al.
Frontiers in Immunology|April 18, 2018
Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4<sup>+</sup> and CD8<sup>+</sup> T-Cell ResponsesJulie Vendomèle, Safa Dehmani, Quentin Khebizi, et al.
Scientific Reports|November 4, 2025
Combined effects of restriction factors and transduction adjuvants on lentiviral vector gene transfer efficacyMarie Dewannieux, Fatoumata Fofana, Kathleen Hamon, et al.
Developmental Biology|August 9, 2002
Activated MAPK/ERK kinase (MEK-1) induces transdifferentiation of pigmented epithelium into neural retinaAnne Galy, Bertrand Néron, Nathalie Planque, et al.
Medecine Sciences : M/S|December 18, 2015
[Efficacy and safety of gene therapy for Wiskott-Aldrich syndrome]Anne Galy, Guillaume Corre, Marina Cavazzana, et al.
International Immunology|October 3, 2002
4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cellsDiego Laderach, Mojgan Movassagh, Anthony Johnson, et al.
Human Gene Therapy Methods|October 25, 2013
Concurrent measures of fusion and transduction efficiency of primary CD34+ cells with human immunodeficiency virus 1-based lentiviral vectors reveal different effects of transduction enhancersDina Ingrao, Saliha Majdoul, Ababacar K Seye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2015
Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 VectorsMaxime Ferrand, Sylvie Da Rocha, Guillaume Corre, et al.
Pageof 11